Predicting SSRI Efficacy in Veterans With PTSD

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial was terminated before it finished — do you know why it was stopped, and does that affect whether the brain-wave biomarker approach it was testing is still considered a valid or promising way to predict whether an SSRI might work for my PTSD?
2. 2The study was trying to use a pre-treatment EEG brain signal called LDAEP to predict how someone would respond to an SSRI after 14 weeks — is that kind of brain-based prediction tool available or useful in my care right now, or is it still purely experimental?
3. 3Since this trial was terminated and didn't complete its full data collection, would my doctor consider a standard 14-week SSRI trial for my PTSD and depression to be a reasonable next step on its own, without waiting for this type of biomarker research to mature?
4. 4This trial enrolled veterans with both PTSD and major depressive disorder — given that I may have one or both of those conditions, how does my specific diagnosis affect which medication options or studies might actually be relevant for me to explore?
5. 5Because this study was terminated, is there another active trial or established clinical pathway my doctor knows of that uses measurable biological markers to guide SSRI treatment decisions for PTSD, so we aren't just relying on trial and error with medications?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.